SUFU and metastatic neoplasm: The results showed a significant decrease in the Sufu expression of metastatic tissues compared with matched primary tumors (Figure 6A–6B, P < 0.0017), which are consistent with the E-cadherin and vimentin expression panels in primary and metastatic tumors (Supplementary Figure S4).